반응식
Cl[CH:2]1[C:7](=[O:8])[CH2:6][C:5]([CH2:14][CH2:15][C:16]2[CH:21]=[CH:20][C:19]([O:22][CH3:23])=[C:18]([Cl:24])[CH:17]=2)([CH:9]2[CH2:13][CH2:12][CH2:11][CH2:10]2)[O:4][C:3]1=[O:25].[CH3:26][N:27]([CH2:29][C:30]1[N:31]([CH3:36])[C:32]([SH:35])=[N:33][N:34]=1)[CH3:28].O.OC1N=CN=C2C=1NC(S)=N2>>[Cl:24][C:18]1[CH:17]=[C:16]([CH2:15][CH2:14][C:5]2([CH:9]3[CH2:13][CH2:12][CH2:11][CH2:10]3)[O:4][C:3](=[O:25])[C:2]([S:35][C:32]3[N:31]([CH3:36])[C:30]([CH2:29][N:27]([CH3:28])[CH3:26])=[N:34][N:33]=3)=[C:7]([OH:8])[CH2:6]2)[CH:21]=[CH:20][C:19]=1[O:22][CH3:23]참가 물질
4
반응물 3
생성물 1
실험 절차
The title compound was prepared as described in Example C(70), where 3-chloro-6-[2-(3-chloro-4-methoxyphenyl)ethyl]-6-cyclopentyldihydro-2H-pyran-2,4(3H)-dione was used in place of 3-chloro-6-[2-(5-chloro-2,4-dimethoxyphenyl)ethyl]6-cyclopentyldihydro-2H-pyran-2,4(3H)-dione and 5-[(dimethylamino)methyl]-4-methyl-4H-1,2,4-triazole-3-thiol, as described in Step 1 of Example C(83), was used in place of 6-hydroxy-8-mercaptopurine monohydrate.
출처 및 근거
- ORD 기록
- ord-e2be339b636e43e9b431c89aa66c1e40
- 출처 데이터셋
- uspto-grants-2006_12
- 특허 번호
- US07148226B2
연결된 노트
불러오는 중…